Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 147

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1
Chunk 147
---
 for Rehearing. Appeal by us (UWA) to the Court of Appeals for the Federal Circuit (Case Nos. 2016-1937, 2016-2086 (consolidated)) voluntarily dismissed July 27, 2017.)  

2.Reissue of U.S. 9,243,245.

3.Reissue of U.S. 7,807,816, which previously was involved in U.S. Patent Interference No. 106,008 (Judgment dated September 20, 2016 ordered cancellation of all claims of U.S. Application No. 13/550,210 to BioMarin (AZL). Appeal by BioMarin (AZL) to the Court of Appeals for the Federal Circuit (Case No. 2017-1078) voluntarily dismissed July 27, 2017.)  

Golodirsen

    Patent Number 
    Country/Region
    Patent Type
    Expiration Date
    Owner/Licensor 

    U.S. RE47,6911
    United States
    Composition of Matter 
    June 28, 2028
    UWA

    U.S. 9,024,007
    United States
    Composition of Matter
    June 28, 2025
    UWA

    U.S. 9,994,8512
    United States
    Composition of Matter
    June 28, 2025
    UWA

    U.S. 10,266,8272
    United States
    Methods of Use
    June 28, 2025
    UWA

    U.S. 10,227,5902
    United States
    Composition of Matter
    June 28, 2025
    UWA

    U.S. 10,421,966
    United States
    Composition of Matter
    June 28, 2025
    UWA

    U.S. 10,968,450
    United States
    Composition of Matter
    June 28, 2025
    UWA

    U.S. 10,995,337
    United States
    Composition of Matter & Methods of Use
    June 28, 2025
    UWA

    EP 2 970 964 B1
    Europe
    Composition of Matter
    March 14, 2034
    Sarepta

1.Reissue